SomaLogic to go public via merger with CM Life Sciences II
SomaLogic, a provider of proteomics technology, has agreed to go public via a merger with CM Life Sciences II, a blank check company backed by Casdin Capital and Corvex Management.
SomaLogic, a provider of proteomics technology, has agreed to go public via a merger with CM Life Sciences II, a blank check company backed by Casdin Capital and Corvex Management.
Copyright PEI Media
Not for publication, email or dissemination